Ibalizumab

Tax included
Ibalizumab (TMB-355) is a humanised IgG4 monoclonal antibody that prevents HIV cell entry by binding to CD4 receptor. Ibalizumab has the potential for HIV-1 infection research.
MedChemExpress 
HY-P99028

Data sheet

Size
Multiple sizes
Reactivity
HIV
Application
COVID-19-anti-virus
CAS
680188-33-4